GLP–1s: A Healthcare Revolution?

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

19 November 2024

The age of GLP-1s is upon us, with the potential to transform healthcare as we know it. What began as a treatment for type 2 diabetes has expanded to reinvent obesity management – and the promise of this drug class extends far beyond these two diseases for which it is currently approved.

In this paper, we highlight the impact of GLP-1s to date, and discuss ongoing research suggesting their game-changing potential in combating some of the world's most prevalent and devastating conditions – both within and outside the metabolic arena. We also consider the implications for future healthcare delivery, cost reduction, and the pharmaceutical industry.

Ultimately, we look into a future where millions of lives could potentially be transformed, healthcare burdens dramatically reduced, and new frontiers of treatment unlocked.